Functional activation of somatostatin- and neuropeptide Y-containing neurons in the entorhinal cortex of chronically epileptic rats

A. Vezzani, R. Monhemius, P. Tutka, R. Milani, R. Samanin

Research output: Contribution to journalArticle

Abstract

The in vitro release of somatostatin and neuropeptide Y, their tissue concentration and immunocytochemical pattern were examined in the entorhinal cortex of chronically epileptic rats. A systemic administration of 12 mg after injection was used to induce, 60 days later, a chronically enhanced susceptibility to seizures in the rats. The release of both peptides under depolarizing conditions was significantly reduced by 15% on average from slices of the entorhinal cortex two days after kainic acid-induced status epilepticus. At 60 days, the spontaneous and 30 mM KCl-induced release of somatostatin was significantly enhanced by 30% on average. The release induced by 100 mM KCl was raised by 70%. The spontaneous, 30 mM and 100 mM KCl-induced release of neuropeptide Y from the same slices was increased, respectively, by 120%, 76% and 36%. The late changes were associated with an increased tissue concentration of neuropeptide Y but not of somatostatin. This was confirmed by immunocytochemical evidence showing that neuropeptide Y-, but not somatostatin-immunoreactive neurons were increased in the entorhinal cortex of kainic acid-treated rats. These results indicate that neurotransmission mediated by somatostatin and neuropeptide Y, two peptides previously shown to play a role in limbic epileptogenesis, is enhanced in the entorhinal cortex of chronically epileptic rats.

Original languageEnglish
Pages (from-to)551-557
Number of pages7
JournalNeuroscience
Volume75
Issue number2
DOIs
Publication statusPublished - Oct 25 1996

Fingerprint

Entorhinal Cortex
Neuropeptide Y
Somatostatin
Neurons
Kainic Acid
Peptides
Status Epilepticus
Synaptic Transmission
Seizures
Injections

Keywords

  • entorhinal cortex
  • epilepsy
  • neuropeptide Y
  • rats
  • seizures
  • somatostatin

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Functional activation of somatostatin- and neuropeptide Y-containing neurons in the entorhinal cortex of chronically epileptic rats. / Vezzani, A.; Monhemius, R.; Tutka, P.; Milani, R.; Samanin, R.

In: Neuroscience, Vol. 75, No. 2, 25.10.1996, p. 551-557.

Research output: Contribution to journalArticle

@article{23491c8187984460ab609c82a4d681eb,
title = "Functional activation of somatostatin- and neuropeptide Y-containing neurons in the entorhinal cortex of chronically epileptic rats",
abstract = "The in vitro release of somatostatin and neuropeptide Y, their tissue concentration and immunocytochemical pattern were examined in the entorhinal cortex of chronically epileptic rats. A systemic administration of 12 mg after injection was used to induce, 60 days later, a chronically enhanced susceptibility to seizures in the rats. The release of both peptides under depolarizing conditions was significantly reduced by 15{\%} on average from slices of the entorhinal cortex two days after kainic acid-induced status epilepticus. At 60 days, the spontaneous and 30 mM KCl-induced release of somatostatin was significantly enhanced by 30{\%} on average. The release induced by 100 mM KCl was raised by 70{\%}. The spontaneous, 30 mM and 100 mM KCl-induced release of neuropeptide Y from the same slices was increased, respectively, by 120{\%}, 76{\%} and 36{\%}. The late changes were associated with an increased tissue concentration of neuropeptide Y but not of somatostatin. This was confirmed by immunocytochemical evidence showing that neuropeptide Y-, but not somatostatin-immunoreactive neurons were increased in the entorhinal cortex of kainic acid-treated rats. These results indicate that neurotransmission mediated by somatostatin and neuropeptide Y, two peptides previously shown to play a role in limbic epileptogenesis, is enhanced in the entorhinal cortex of chronically epileptic rats.",
keywords = "entorhinal cortex, epilepsy, neuropeptide Y, rats, seizures, somatostatin",
author = "A. Vezzani and R. Monhemius and P. Tutka and R. Milani and R. Samanin",
year = "1996",
month = "10",
day = "25",
doi = "10.1016/0306-4522(96)00261-8",
language = "English",
volume = "75",
pages = "551--557",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Functional activation of somatostatin- and neuropeptide Y-containing neurons in the entorhinal cortex of chronically epileptic rats

AU - Vezzani, A.

AU - Monhemius, R.

AU - Tutka, P.

AU - Milani, R.

AU - Samanin, R.

PY - 1996/10/25

Y1 - 1996/10/25

N2 - The in vitro release of somatostatin and neuropeptide Y, their tissue concentration and immunocytochemical pattern were examined in the entorhinal cortex of chronically epileptic rats. A systemic administration of 12 mg after injection was used to induce, 60 days later, a chronically enhanced susceptibility to seizures in the rats. The release of both peptides under depolarizing conditions was significantly reduced by 15% on average from slices of the entorhinal cortex two days after kainic acid-induced status epilepticus. At 60 days, the spontaneous and 30 mM KCl-induced release of somatostatin was significantly enhanced by 30% on average. The release induced by 100 mM KCl was raised by 70%. The spontaneous, 30 mM and 100 mM KCl-induced release of neuropeptide Y from the same slices was increased, respectively, by 120%, 76% and 36%. The late changes were associated with an increased tissue concentration of neuropeptide Y but not of somatostatin. This was confirmed by immunocytochemical evidence showing that neuropeptide Y-, but not somatostatin-immunoreactive neurons were increased in the entorhinal cortex of kainic acid-treated rats. These results indicate that neurotransmission mediated by somatostatin and neuropeptide Y, two peptides previously shown to play a role in limbic epileptogenesis, is enhanced in the entorhinal cortex of chronically epileptic rats.

AB - The in vitro release of somatostatin and neuropeptide Y, their tissue concentration and immunocytochemical pattern were examined in the entorhinal cortex of chronically epileptic rats. A systemic administration of 12 mg after injection was used to induce, 60 days later, a chronically enhanced susceptibility to seizures in the rats. The release of both peptides under depolarizing conditions was significantly reduced by 15% on average from slices of the entorhinal cortex two days after kainic acid-induced status epilepticus. At 60 days, the spontaneous and 30 mM KCl-induced release of somatostatin was significantly enhanced by 30% on average. The release induced by 100 mM KCl was raised by 70%. The spontaneous, 30 mM and 100 mM KCl-induced release of neuropeptide Y from the same slices was increased, respectively, by 120%, 76% and 36%. The late changes were associated with an increased tissue concentration of neuropeptide Y but not of somatostatin. This was confirmed by immunocytochemical evidence showing that neuropeptide Y-, but not somatostatin-immunoreactive neurons were increased in the entorhinal cortex of kainic acid-treated rats. These results indicate that neurotransmission mediated by somatostatin and neuropeptide Y, two peptides previously shown to play a role in limbic epileptogenesis, is enhanced in the entorhinal cortex of chronically epileptic rats.

KW - entorhinal cortex

KW - epilepsy

KW - neuropeptide Y

KW - rats

KW - seizures

KW - somatostatin

UR - http://www.scopus.com/inward/record.url?scp=0030601662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030601662&partnerID=8YFLogxK

U2 - 10.1016/0306-4522(96)00261-8

DO - 10.1016/0306-4522(96)00261-8

M3 - Article

C2 - 8931018

AN - SCOPUS:0030601662

VL - 75

SP - 551

EP - 557

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 2

ER -